IDEX Corporation (IEX)

Investment Committee Summary

Investment Thesis

At $234 (25 August 2026) IDEX changes hands on about 28 times forward earnings, a modest premium to the diversified-industrial peer median. Spot embeds the market's belief that this remains a high-return, cash-generative compounder: low-single-digit organic volume, an operating margin near the reported 21%, and steady bolt-on acquisitions funded from cash conversion that exceeds reported earnings. The engine broadly agrees on the business quality and not on the entry price. The twelve-month target of $227 and the probability-weighted $216 sit at or beneath today's price, and the peer and discounted-cash-flow reads pull below the market multiple rather than supporting it, so the triangulated $195 leaves the shares trading rich to the blend at -16%. That is the HOLD case: the weighted fair value offers no margin of safety, the multiple rather than earnings drives most of the modelled dispersion, and net debt of ~$1.3B is modest enough that the balance sheet neither helps nor hurts the argument. The single most damaging risk is a short-cycle destock — factory activity turning contractionary alongside a channel-inventory reset would take organic growth negative, expose decremental margins, and de-rate a premium multiple simultaneously.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($234) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The highest-probability bear here is structural rather than merely cyclical. IDEX is an assembly of small, high-margin fluidics and dosing niches, and a premium multiple assumes each niche keeps its pricing power indefinitely. If one core platform loses relevance to a substitute technology, or an acquired business proves to have been overpaid for and is later written down, revenue falls while fixed cost is absorbed on a smaller base and the operating margin de-rates from the reported 21% toward the mid-teens. The multiple compresses at the same time and for a different reason: the market re-prices the compounder narrative rather than merely the current cycle, and a serial acquirer whose acquisitions stop compounding is valued as an industrial rather than as a platform. Earnings and the multiple fall together; the structural path carries a target below the fifty-two-week low, and cash conversion weakens exactly as the acquisition engine that justified the rating stalls.

Key Debate

P/E Multiple explains 60% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 26.5× consensus forward EPS, vs the house DCF terminal 23.0×, and a peer median 26.3×. The house DCF sits 24% below spot, so the market is pricing in more than the house case — roughly 2.5pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Portfolio / End-Market Disruption' downside ($94.90) to a 'Bull — Re-Rate' bull case ($384); the probability-weighted blend (PWEV $216) is -7% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.8% of revenue; free cash flow net of SBC is $0.59B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — Portfolio / End-Market Disruption (20%, $94.90). Structural impairment — portfolio / end-market disruption: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Industrial-PMI Recession (17%, $161). Cyclical downturn — short-cycle industrial demand (PMI) + price/cost spread + aftermarket weakens for 1–2 years before normalising.
• Base — Organic Growth + Margin (35%, $226). Mid-cycle — normalised short-cycle industrial demand (PMI) + price/cost spread + aftermarket; disciplined capital allocation; steady returns.
• Growth — Productivity / Reshoring / Automation (20%, $302). Upside — productivity + reshoring + automation lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Re-Rate (8%, $384). Upside tail — sustained tight conditions or a structural re-rate on productivity + reshoring + automation.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $204 + scenario PWEV $216, ≈ spot); the weighted blend $195 (-16%) sits below it because the cash-flow DCF ($176) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $204 and 38% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (60% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.0%, 23.0x terminal FCF multiple → $176. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $216; the peer-median forward P/E is 26.3x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 19% of the median — moderate (healthy method disagreement — read the blend with care).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Diversified Industrials (equipment + aftermarket) multiple (AI re-rating) (base 27.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 26.5× (simple median 26.3×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $155–$241, centre $193 (-17% vs spot); spot sits at the 92nd percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Re-Rate): $384.

Company Overview & Business Model

IDEX Corporation — INDUSTRIALS · SPECIALTY INDUSTRIAL MACHINERY. IDEX Corporation, based in Northbrook, Illinois, is a publicly traded company engaged in the development, design, and manufacture of fluidics systems and specialty engineered products.

How it makes money.

Edge. Narrow moat — IDEX's moat is a portfolio of niche, mission-critical fluidics/dispensing components with high engineering specification lock-in and pricing power, but no single dominant franchise, so the moat is narrow-to-solid rather than wide. FALSIFIABLE: if organic growth stalls below GDP with flat-to-down margins for two years (no reshoring/automation lift), the ~27x forward multiple exceeds the diversified-industrial ~26x peer median without justification and should compress toward or below it.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 141% — cash-backed.

Competitive Moat

Moat sources:

• Spec-in / designed-in position on mission-critical fluidics and precision components (switching costs, FACT/INFERENCE)
• Niche-market leadership across many small, hard-to-disrupt end-markets (diversification, FACT)
• Pricing power and >100% cash conversion funding disciplined bolt-on M&A (FACT)
• No single franchise dominant enough to constitute a wide moat (INFERENCE)

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q2): management +0.64 vs analyst floor +0.02 → delta +0.62 (n=25 mgmt / 19 Q&A; 90th pctile across the S&P book, z +1.3).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

News (last 365d, 867 articles): avg ticker sentiment +0.23 (bullish 41% / bearish 2%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-25 (~62d) — New-product / platform launch in health & science or fire & safety segment (authored)
• 2026-11-12 (~80d) — Investor/analyst day or updated capital-allocation / M&A framework (authored)
• 2027-02-15 (~175d) — Reshoring / automation-demand end-market inflection (industrial PMI recovery) (authored)

Forecast Track Record

• EPS surprise: beat 100% of the last 8 quarters; average surprise +5.5%.
• Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 67%; mean predicted -0.4% vs realised +2.5%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

6 catalysts in the next 90 days (of 15 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Regulatory & Legal Risk

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic revenue growth (constant currency, ex-M&A) < 0.01 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Adjusted (non-GAAP) operating margin < 0.2 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Book-to-bill (orders / revenue) in short-cycle segments < 0.95 (2 consecutive prints). Book-to-bill leads revenue for short-cycle machinery. Two quarters below 0.95 would flag a forward volume shortfall against the base-case low-single-digit organic assumption before it appears in reported sales.
• Trailing FCF conversion (FCF / adjusted net income) < 0.9 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
• Goodwill and intangible impairment charge > 0.2 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $234; 52-week range $155–$241; engine rating HOLD; house target $227 (-3%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
• INFERENCE: Triangulated FV $195 (-16% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

65.1/100 (confidence band 52.8–77.4), 77th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.

Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.

Score history: 65.9 → 65.9 → 65.8 → 66.4 → 66.4 → 65.5 → 65.5 → 65.5.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $216.49.

Factor Exposures

Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.53, vs QQQ +0.42 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
• Direction neutral from the overlay conviction/rating (read-only input).
• IV/RV at the 86th percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 42nd percentile of its own month-end history (decile 5). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +2.0pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +2.0pp): 25-DTE 24% · 53-DTE 26% · 235-DTE 26%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 23.9% (elevated regime) · expected move ±5.1% (2026-09-18) · put/call OI 0.41 · ATM Δ 0.63 / Θ -0.12 / ν 0.23. Direction: NEUTRAL (implied return -16.4% to triangulated fair value $195.27).

Covered Call (if held) (Income / neutral) — Short 250 C · 2026-09-18 · premium $0.01 · yield 0.0% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Elevated implied volatility currently enriches the premium collected. Illustrative — no outcome is implied or guaranteed.

Protective Collar (if held) (Hedge) — Long 210 P / Short 260 C · 2027-01-15 · net $0.75 · floor -10.0% · cap +11.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies -7% vs spot
• Monte Carlo median implies -13% vs spot
• DCF fair value implies -24% vs spot — but this is terminal-value sensitive (exit-multiple $176 vs Gordon $127, 28% apart), so it carries less weight
• Bear case (Structural — Portfolio / End-Market Disruption) downside is -59% vs spot
• Net: the valuation anchor itself sits 16.4% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.0% · Σ PV(FCF) $3B + PV(terminal) $12B = EV $14B; − net debt $1.3B → equity $13B ÷ diluted shares $0.07B = $176/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $127/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 41% vs WACC 9.0% → above WACC — the build is value-creative.

Peer set

Implied prices at the peer medians: EV/Rev → $216 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (52.0); Op margin ±3pp (52.0); Terminal × ±15% (47.0); WACC ±1pp (16.0); Capex intensity ±15% (6.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 9.0%, terminal multiple 23×, FY+5 revenue $4B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.